- Home
- SPOK vs ZURA Comparison
SPOK vs ZURA Comparison
Compare SPOK & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPOK
- ZURA
- Stock Information
- Founded
- SPOK 2004
- ZURA 2022
- Country
- SPOK United States
- ZURA United States
- Employees
- SPOK N/A
- ZURA N/A
- Industry
- SPOK Telecommunications Equipment
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPOK Telecommunications
- ZURA Health Care
- Exchange
- SPOK Nasdaq
- ZURA Nasdaq
- Market Cap
- SPOK 329.2M
- ZURA 292.1M
- IPO Year
- SPOK 1992
- ZURA N/A
- Fundamental
- Price
- SPOK $15.92
- ZURA $1.77
- Analyst Decision
- SPOK Hold
- ZURA Buy
- Analyst Count
- SPOK 1
- ZURA 6
- Target Price
- SPOK $15.00
- ZURA $15.80
- AVG Volume (30 Days)
- SPOK 98.5K
- ZURA 613.7K
- Earning Date
- SPOK 02-19-2025
- ZURA 03-12-2025
- Dividend Yield
- SPOK 7.86%
- ZURA N/A
- EPS Growth
- SPOK N/A
- ZURA N/A
- EPS
- SPOK 0.71
- ZURA N/A
- Revenue
- SPOK $137,714,000.00
- ZURA N/A
- Revenue This Year
- SPOK $2.45
- ZURA N/A
- Revenue Next Year
- SPOK $0.80
- ZURA N/A
- P/E Ratio
- SPOK $22.41
- ZURA N/A
- Revenue Growth
- SPOK N/A
- ZURA N/A
- 52 Week Low
- SPOK $13.24
- ZURA $1.76
- 52 Week High
- SPOK $18.14
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- SPOK 47.46
- ZURA 30.04
- Support Level
- SPOK $15.32
- ZURA $1.86
- Resistance Level
- SPOK $16.25
- ZURA $2.08
- Average True Range (ATR)
- SPOK 0.30
- ZURA 0.21
- MACD
- SPOK 0.02
- ZURA -0.03
- Stochastic Oscillator
- SPOK 61.22
- ZURA 1.55
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.